Rare and Complex Urology: Clinical Overview of ERN eUROGEN.

Eur Urol

Department of Urology, Division of Paediatric Urology, Radboudumc Amalia Children's Hospital, Nijmegen, The Netherlands. Electronic address:

Published: February 2022


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Background: In 2017, the European Commission launched 24 European Reference Networks (ERNs). ERN eUROGEN is the network for urorectogenital diseases and complex conditions, and started with 29 full member healthcare providers (HCPs) in 11 countries. It then covered 19 different disease areas distributed over three workstreams (WSs).

Objective: To provide an overview and identify challenges in data collection at European level of the ERN eUROGEN patient population treated by HCPs in the network.

Design, Setting, And Participants: A retrospective cohort study was conducted of the 29 HCPs who were full members between 2013 and 2019.

Outcome Measurements And Statistical Analysis: Data were extracted from the original HCP applications and the ERN continuous monitoring system. Patient volumes, new patient numbers, and procedures were compared between different WSs, countries, and HCPs. Discrepancies between monitoring and application data were identified.

Results And Limitations: Between 2013 and 2019, 122 040 patients required long-term care within the 29 HCPs. The volume of patients treated and procedures undertaken per year increased over time. Large discrepancies were found between patient numbers contained in the application forms and those reported in the continuous monitoring system (0-1357% deviation).

Conclusions: Patient numbers and procedures increased across ERN eUROGEN HCPs. Reliable data extraction appeared challenging, illustrated by the patient volume discrepancies between application forms and the continuous monitoring data. Improved disease definitions, re-evaluation of affiliated HCPs, and valid data extraction are needed for future improvements.

Patient Summary: We analysed the patient population with rare urorectogenital diseases or complex conditions within the ERN eUROGEN network between 2013 and 2019. Clinical activity was found to increase, but differences in patient numbers were evident between healthcare providers. In order to acquire valid patient numbers, both improved definitions of diagnostic codes and greater insight into the data-gathering process are required.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.eururo.2021.02.043DOI Listing

Publication Analysis

Top Keywords

ern eurogen
20
patient numbers
20
continuous monitoring
12
patient
9
eurogen network
8
urorectogenital diseases
8
diseases complex
8
complex conditions
8
healthcare providers
8
patient population
8

Similar Publications

The European Reference Network eUROGEN, an interview by the Journal of Pediatric Urology.

J Pediatr Urol

August 2025

Department of Pediatric Surgery, Rigshospitalet, Clinical Medicine, Copenhagen University, Copenhagen, Denmark; Department of Women's and Children's Health, Center for Molecular Medicine, Karolinska Institutet, Stockholm, Sweden. Electronic address:

The European Reference Networks (ERNs) initiative was started by the European Commission. The initiative was launched in 2017 in response to the 2011 EU Directive on Cross-Border Healthcare (Directive 2011/24/EU), which emphasized the need to improve healthcare for patients with rare diseases and complex conditions across the European Union. Currently, 24 ERNs are available for rare diseases.

View Article and Find Full Text PDF

Comparison of Three Different Staging Systems Capable of Predicting the Severity of Congenital Lower Urinary Tract Obstruction (LUTO) and Its Prognosis.

J Clin Ultrasound

August 2025

Division of Maternal-Fetal Medicine, Department of Maternal and Fetal Medicine, Obstetrics and Gynecology, University of Miami, Miller School of Medicine, Miami, Florida, USA.

Lower urinary tract obstruction (LUTO) is a rare but severe fetal condition associated with significant morbidity and long-term renal risk. Several prenatal staging systems have been proposed to guide management and predict outcomes, yet their comparative prognostic value remains uncertain. This review provides a structured evaluation of three staging systems currently used in clinical practice: those proposed by Ruano, Fontanella, and Nassr.

View Article and Find Full Text PDF

Introduction: Lower urinary tract symptoms (LUTS) are known to significantly affect health-related quality of life, often leading to psychological and social challenges. Despite the prevalence of paediatric and adult LUTS, the needs for, and the process of transition from childhood to adolescence and young adulthood remain both poorly understood or defined, with many patients lacking organized follow-up care.

Methods: This article summarizes discussions during an NOPIA Research Meeting following the International Consultation on Incontinence - Research Society (ICI-RS) 2024 on the topic of LUTS management practices in childhood and adolescence, and evaluates existing transition models in this population.

View Article and Find Full Text PDF

Button Cystostomy in Children with Neurogenic Bladder: Outcomes from a Single Center.

J Clin Med

August 2025

Division of Neuro-Urology, Bambino Gesù Children's Hospital, IRCCS, ERN eUROGEN Affiliated Center, Piazza di Sant'Onofrio 4, 00165 Rome, Italy.

: Neurogenic bladder (NB) in children may lead to recurrent urinary tract infections (UTIs), renal deterioration, and a reduced quality of life. Clean intermittent catheterization (CIC) is the standard of care, but in some patients, CIC may be unfeasible due to anatomical, sensory, or compliance issues. Button cystostomy (BC) has emerged as a minimally invasive, bladder-preserving alternative.

View Article and Find Full Text PDF

Vesicoureteral reflux (VUR) management in children with neurogenic bladder dysfunction (NBD) remains a clinical challenge. Total endoscopic management (TEM), combining intradetrusor Onabotulinum Toxin-A (BTX-A) and subureteric dextranomer/hyaluronic acid (Deflux) injection, offers a minimally invasive alternative. The aim of this retrospective study is to evaluate the long-term effectiveness of TEM.

View Article and Find Full Text PDF